Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Identifying Bacterial Vaginosis-Associated Bacteria Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

April 3, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Bacterial Vaginosis
    Bacterial Vaginosis

    Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-03-24

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What Was Studied?

This study analyzed bacterial vaginosis-associated bacteria (BVAB) at the species level using DNA sequencing and phylogenetic analysis. Researchers sought to identify the exact species of BVAB-1, BVAB-2, and BVAB-3, which were previously unknown and only classified by molecular signatures. By applying metagenomic sequencing and comparative analysis, the study aimed to provide clarity on the taxonomy of these bacteria and their role in bacterial vaginosis (BV) pathogenesis.

Who Was Studied?

The study analyzed bacterial DNA extracted from vaginal specimens of women diagnosed with BV. Using genomic data from previous metagenomic studies, the researchers compared BVAB sequences to known bacterial genomes, identifying their closest relatives and evolutionary relationships.

Key Findings and Microbial Associations

The study successfully identified the species of three previously unclassified BV-associated bacteria. BVAB-1 was found to be Clostridiales genomosp. BVAB-1 (later renamed Candidatus Lachnocurva vaginae), BVAB-2 was classified as Oscillospiraceae bacterium strain CHIC02, and BVAB-3 was identified as Mageeibacillus indolicus. These species, previously unknown, are strictly anaerobic and uncultivable in standard laboratory conditions. Their identification provides a more detailed understanding of the microbial shifts in BV and offers new insights into their role in vaginal dysbiosis.

The findings reinforce the idea that BV is not caused by a single pathogen but by a complex shift in the vaginal microbiome. The presence of BVAB-1, BVAB-2, and BVAB-3 in women with BV suggests they may contribute to the condition’s persistence and recurrence. By using metagenomic sequencing and phylogenetic analysis, the study clarifies the taxonomy of these bacteria and their evolutionary relationships. This species-level identification allows for improved diagnostics and targeted research into BV-associated microbial interactions.

Implications of the Study

Identifying the specific species associated with BV significantly improves diagnostic and treatment strategies. Clinicians currently use broad-spectrum antibiotics to treat BV, but discovering these species enables the development of more targeted therapies. This study also emphasizes the need for continued metagenomic research, as many BV-associated bacteria are difficult to culture and study in traditional lab settings. With more precise species identification, researchers can better understand how these bacteria interact with the vaginal microbiome and contribute to BV recurrence.

Bacterial Vaginosis

Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.